Jessica Hurt

Company: Biogen Idec
Job title: Director, Genomic Targets Biology
Seminars:
Ataxin-2 ASO for the Treatment of Broad ALS 8:00 am
• Review learnings from prior ALS ASO programs • Present evidence supporting Ataxin-2 as a potential modifier of broad ALS • Development of an RNAseH-dependent ASO against Ataxin-2Read more
day: Day One AM
Kick-Off Panel Discussion Taking on CNS Disease with Oligonucleotides: What’s Hot? 7:30 am
Gathering together as the agenda kicks off to discuss the latest in technology, big oligo industry news, and excitement for the year aheadRead more
day: Day One AM